The rapid growth of the market for the
outsourcing of the drug development pipeline to
Contract Research Organisations (CRO) has been
phenomenal since the turn of the century. Today
it is estimated to be just below the $20 billion per
annum mark and estimated to grow to $23.7bn
by 2010[1]. Integral to the growth of this market
place is the skill of Scientists such as the Principal
Investigators (PI) who lead and are legally
responsible for the conduct of the studies. They
develop assays but also have to be extremely
competent with high end Analytical
Instrumentation such as LC-MS/MS, which is very
much the workhorse of many CRO Laboratories.
Bernie Monaghan Editor for the Separations
Science and Spectroscopy sections of International
Labmate, visited BioAnalytical Systems (BASi)
based in Warwickshire, UK to speak with James
Hillis and Mark Wareing the Operations and
Managing Directors respectively of this medium
sized CRO to discuss the current issues of
workload, customer expectations and identifying
and meeting technical challenges for the future.
Product directory
